marketcaparena
Search

    MRNA

    Moderna, Inc.

    Company overview

    Market capitalization
    $78.76B
    Employees
    4,700
    Latest publication
    2026-09-29
    About Moderna, Inc.

    Moderna, Inc., a biotechnology company, provides messenger RNA medicines in the United States, Europe, and internationally. The company's respiratory vaccines include spikevax, mNEXSPIKE, mRESVIA, COVID, RSV, seasonal influenza, combination, and pandemic influenza vaccine; latent vaccines comprise cytomegalovirus, epstein-barr virus, and human immunodeficiency virus vaccines; enteric viruses include norovirus; public health vaccines consist of Zika, Nipah, and Mpox vaccines; and bacterial diseases vaccines, such as lyme vaccines. It also provides oncology therapeutics, such as intismeran autogene, cancer antigen therapy, t-cell engager, and cell therapy enhancer; and rare disease products, including propionic and methylmalonic acidemia, and cystic fibrosis. It has strategic alliances and collaborations with Merck & Co., Inc; Vertex Pharmaceuticals Incorporated; Vertex Pharmaceuticals (Europe) Limited; immatics N.V.; Defense Advanced Research Projects Agency; Biomedical Advanced Research and Development Authority; Institute for Life Changing Medicines; The Bill & Melinda Gates Foundation; and OpenAI. The company was formerly known as Moderna Therapeutics, Inc. and changed its name to Moderna, Inc. in August 2018. Moderna, Inc. was founded in 2010 and is headquartered in Cambridge, Massachusetts.

    Company website

    Financial statements

    Income Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ2 20262026-06-30 · USDQ4 20232023-12-31 · USDQ4 20222022-12-31 · USDQ3 20222022-09-30 · USDQ2 20222022-06-30 · USDQ1 20222022-03-31 · USDQ4 20212021-12-31 · USDQ3 20212021-09-30 · USD
    Total Revenue145,000,000USD2,813,000,000USD5,149,000,000USD3,220,000,000USD4,566,000,000USD5,940,000,000USD6,949,000,000USD4,829,000,000USD
    Cost Of Revenue93,000,000USD929,000,000USD1,918,000,000USD1,100,000,000USD1,381,000,000USD1,017,000,000USD952,000,000USD722,000,000USD
    Gross Profit52,000,000USD1,884,000,000USD3,231,000,000USD2,120,000,000USD3,185,000,000USD4,923,000,000USD5,997,000,000USD4,107,000,000USD
    Research Development651,000,000USD1,406,000,000USD1,211,000,000USD820,000,000USD710,000,000USD554,000,000USD648,000,000USD521,000,000USD
    Selling General Administrative216,000,000USD266,000,000USD254,000,000USD278,000,000USD211,000,000USD268,000,000USD201,000,000USD168,000,000USD
    General And Administrative Expenses216,000,000USD———————
    Total Operating Expenses867,000,000USD1,878,000,000USD1,651,000,000USD954,000,000USD738,000,000USD696,000,000USD587,000,000USD549,000,000USD
    Operating Income-815,000,000USD6,000,000USD1,580,000,000USD1,166,000,000USD2,447,000,000USD4,227,000,000USD5,410,000,000USD3,558,000,000USD
    Total Other Income Expense Net48,000,000USD64,000,000USD75,000,000USD51,000,000USD27,000,000USD2,000,000USD-7,000,000USD-6,000,000USD
    Interest Income67,000,000USD103,000,000USD87,000,000USD58,000,000USD40,000,000USD15,000,000USD7,000,000USD4,000,000USD
    Income Before Tax-767,000,000USD70,000,000USD1,655,000,000USD1,217,000,000USD2,474,000,000USD4,229,000,000USD5,410,000,000USD3,552,000,000USD
    Income Tax Expense15,000,000USD-147,000,000USD190,000,000USD174,000,000USD277,000,000USD572,000,000USD542,000,000USD219,000,000USD
    Net Income-782,000,000USD217,000,000USD1,465,000,000USD1,043,000,000USD2,197,000,000USD3,657,000,000USD4,868,000,000USD3,333,000,000USD
    Selling And Marketing Expenses—204,000,000USD121,000,000USD—————
    Interest Expense—6,000,000USD10,000,000USD8,000,000USD5,000,000USD6,000,000USD6,000,000USD4,000,000USD
    Net Interest Income—97,000,000USD87,000,000USD50,000,000USD40,000,000USD9,000,000USD1,000,000USD0USD
    Tax Provision—-147,000,000USD190,000,000USD174,000,000USD277,000,000USD572,000,000USD542,000,000USD219,000,000USD
    Net Income From Continuing Ops—217,000,000USD1,465,000,000USD1,043,000,000USD2,197,000,000USD3,657,000,000USD4,868,000,000USD3,333,000,000USD
    Ebit—76,000,000USD1,665,000,000USD1,225,000,000USD2,479,000,000USD4,227,000,000USD5,410,000,000USD3,556,000,000USD
    Ebitda—278,000,000USD1,745,000,000USD1,338,000,000USD2,555,000,000USD4,306,000,000USD5,488,000,000USD3,626,000,000USD
    Depreciation And Amortization—202,000,000USD80,000,000USD113,000,000USD76,000,000USD79,000,000USD78,000,000USD70,000,000USD
    Reconciled Depreciation—202,000,000USD80,000,000USD113,000,000USD76,000,000USD79,000,000USD78,000,000USD70,000,000USD
    Unclassified Operating Expenses——65,000,000USD-144,000,000USD-183,000,000USD-126,000,000USD-262,000,000USD-140,000,000USD
    Non Operating Income Net Other——75,000,000USD51,000,000USD27,000,000USD2,000,000USD—-6,000,000USD
    Net Income Applicable To Common Shares——1,465,000,000USD1,043,000,000USD2,197,000,000USD3,657,000,000USD4,868,000,000USD3,333,000,000USD
    SourceDisclosureDeterministicFinalLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Income Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20222022-12-31 · USDFY 20212021-12-31 · USDFY 20192019-12-31 · USDFY 20182018-12-31 · USDFY 20152015-12-31 · USDFY 20142014-12-31 · USD
    Total Revenue18,875,000,000USD17,736,000,000USD48,036,000USD122,512,000USD0USD500,000USD
    Cost Of Revenue5,416,000,000USD2,617,000,000USD496,309,000USD454,082,000USD0USD0USD
    Gross Profit13,459,000,000USD15,119,000,000USD48,036,000USD-331,570,000USD0USD500,000USD
    Research Development3,295,000,000USD1,991,000,000USD496,309,000USD454,082,000USD322,317USD686,000USD
    Selling General Administrative1,011,000,000USD567,000,000USD109,620,000USD94,252,000USD785,261USD3,334,000USD
    Unclassified Operating Expenses-267,000,000USD-735,000,000USD-12,173,000USD-12,556,000USD—-4,020,000USD
    Total Operating Expenses4,039,000,000USD1,823,000,000USD593,756,000USD535,778,000USD1,107,578USD0USD
    Operating Income9,420,000,000USD13,296,000,000USD-545,720,000USD-413,266,000USD-1,107,578USD-3,520,000USD
    Interest Income200,000,000USD18,000,000USD38,530,000USD27,023,000USD——
    Interest Expense29,000,000USD18,000,000USD6,612,000USD3,096,000USD0USD0USD
    Net Interest Income200,000,000USD18,000,000USD31,918,000USD27,023,000USD——
    Income Before Tax9,575,000,000USD13,285,000,000USD-514,716,000USD-384,408,000USD-1,106,964USD-6,482,000USD
    Income Tax Expense1,213,000,000USD1,083,000,000USD-695,000USD326,000USD1,600USD0USD
    Tax Provision1,213,000,000USD1,083,000,000USD-695,000USD326,000USD——
    Net Income8,362,000,000USD12,202,000,000USD-514,021,000USD-384,734,000USD-1,108,564USD-6,477,000USD
    Net Income From Continuing Ops8,362,000,000USD12,202,000,000USD-514,021,000USD-384,734,000USD-1,108,564USD-6,477,000USD
    Ebit9,604,000,000USD13,296,000,000USD-545,720,000USD-413,266,000USD-1,107,578USD-5,476,000USD
    Ebitda9,952,000,000USD13,528,000,000USD-514,699,000USD-388,404,000USD——
    Depreciation And Amortization348,000,000USD232,000,000USD31,021,000USD24,862,000USD——
    Reconciled Depreciation348,000,000USD232,000,000USD31,021,000USD24,862,000USD——
    Total Other Income Expense Net155,000,000USD-11,000,000USD31,004,000USD1,835,000USD614USD-1,951,000USD
    Non Operating Income Net Other155,000,000USD-11,000,000USD31,004,000USD28,858,000USD——
    Net Income Applicable To Common Shares8,362,000,000USD12,202,000,000USD-514,021,000USD-401,857,000USD-1,108,564USD-12,477,000USD
    Other Operating Expenses————49,189USD—
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Balance sheet Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ2 20262026-06-30 · USDQ1 20262026-03-31 · USDQ4 20252025-12-31 · USDQ3 20252025-09-30 · USDQ2 20252025-06-30 · USDQ1 20252025-03-31 · USDQ4 20242024-12-31 · USDQ3 20242024-09-30 · USD
    Total Assets10,961,000,000USD11,488,000,000USD12,338,000,000USD12,135,000,000USD12,010,000,000USD12,704,000,000USD14,142,000,000USD15,803,000,000USD
    Cash And Equivalents1,723,000,000USD———————
    Total Current Assets5,815,000,000USD5,770,000,000USD6,544,000,000USD6,598,000,000USD6,171,000,000USD6,766,000,000USD8,099,000,000USD9,666,000,000USD
    Other Current Assets42,000,000USD272,000,000USD308,000,000USD367,000,000USD343,000,000USD357,000,000USD365,000,000USD551,000,000USD
    Other Non Current Assets618,000,000USD———————
    Total Liabilities4,200,000,000USD———————
    Total Current Liabilities2,534,000,000USD2,395,000,000USD1,987,000,000USD1,681,000,000USD1,572,000,000USD1,604,000,000USD2,206,000,000USD2,201,000,000USD
    Other Current Liabilities163,000,000USD———————
    Other Non Current Liabilities284,000,000USD———————
    Total Stockholder Equity6,761,000,000USD7,408,000,000USD8,650,000,000USD9,330,000,000USD9,399,000,000USD10,066,000,000USD10,901,000,000USD11,927,000,000USD
    Total Equity Including Noncontrolling Interest6,761,000,000USD———————
    Long Term Debt591,000,000USD590,000,000USD590,000,000USD—————
    Deferred Revenue295,000,000USD———————
    Deferred Revenue Non Current147,000,000USD———————
    Net Receivables17,000,000USD147,000,000USD284,000,000USD1,394,000,000USD457,000,000USD306,000,000USD592,000,000USD1,836,000,000USD
    Inventory280,000,000USD146,000,000USD153,000,000USD332,000,000USD240,000,000USD128,000,000USD117,000,000USD412,000,000USD
    Property Plant Equipment Net2,756,000,000USD2,792,000,000USD2,853,000,000USD2,864,000,000USD2,919,000,000USD2,964,000,000USD2,955,000,000USD3,165,000,000USD
    Goodwill52,000,000USD———————
    Accounts Payable167,000,000USD161,000,000USD317,000,000USD267,000,000USD175,000,000USD226,000,000USD405,000,000USD373,000,000USD
    Short Term Debt21,000,000USD50,000,000USD—48,000,000USD43,000,000USD43,000,000USD37,000,000USD51,000,000USD
    Common Stock0USD———————
    Retained Earnings5,098,000,000USD5,880,000,000USD7,223,000,000USD8,049,000,000USD8,249,000,000USD9,074,000,000USD10,045,000,000USD11,165,000,000USD
    Accumulated Other Comprehensive Income19,000,000USD25,000,000USD45,000,000USD27,000,000USD23,000,000USD10,000,000USD-10,000,000USD11,000,000USD
    Intangible Assets—116,000,000USD45,000,000USD47,000,000USD48,000,000USD49,000,000USD40,000,000USD41,000,000USD
    Total Liab—4,080,000,000USD3,688,000,000USD2,805,000,000USD2,611,000,000USD2,638,000,000USD3,241,000,000USD3,876,000,000USD
    Other Current Liab—2,082,000,000USD1,571,000,000USD1,203,000,000USD1,136,000,000USD1,210,000,000USD1,608,000,000USD1,394,000,000USD
    Capital Stock—0USD0USD0USD0USD0USD0USD0USD
    Good Will—52,000,000USD52,000,000USD52,000,000USD52,000,000USD52,000,000USD52,000,000USD52,000,000USD
    Cash—1,908,000,000USD2,595,000,000USD1,132,000,000USD1,279,000,000USD1,623,000,000USD1,927,000,000USD1,644,000,000USD
    Cash And Short Term Investments—5,205,000,000USD5,799,000,000USD4,505,000,000USD5,131,000,000USD5,975,000,000USD7,025,000,000USD6,867,000,000USD
    Current Deferred Revenue—102,000,000USD99,000,000USD163,000,000USD218,000,000USD125,000,000USD153,000,000USD379,000,000USD
    Net Debt—-610,000,000USD-679,000,000USD261,000,000USD-538,000,000USD-878,000,000USD-1,180,000,000USD-289,000,000USD
    Short Long Term Debt Total—1,298,000,000USD1,916,000,000USD1,394,000,000USD741,000,000USD745,000,000USD747,000,000USD1,355,000,000USD
    Long Term Investments—2,251,000,000USD2,342,000,000USD2,152,000,000USD2,380,000,000USD2,424,000,000USD2,508,000,000USD2,358,000,000USD
    Short Term Investments—3,297,000,000USD3,204,000,000USD3,372,000,000USD3,852,000,000USD4,352,000,000USD5,098,000,000USD5,223,000,000USD
    Property Plant Equipment Gross—3,586,000,000USD3,590,000,000USD3,535,000,000USD3,542,000,000USD3,530,000,000USD3,482,000,000USD3,716,000,000USD
    Common Stock Shares Outstanding—395,000,000shares392,000,000shares390,000,000shares388,000,000shares386,000,000shares385,000,000shares399,000,000shares
    Non Current Assets Total—5,718,000,000USD5,794,000,000USD5,537,000,000USD5,839,000,000USD5,938,000,000USD6,043,000,000USD6,137,000,000USD
    Non Current Liabilities Total—1,685,000,000USD1,701,000,000USD1,124,000,000USD1,039,000,000USD1,034,000,000USD1,035,000,000USD1,675,000,000USD
    Non Current Liabilities Other—30,000,000USD36,000,000USD42,000,000USD39,000,000USD40,000,000USD36,000,000USD35,000,000USD
    Non Currrent Assets Other—263,000,000USD421,000,000USD241,000,000USD359,000,000USD368,000,000USD407,000,000USD440,000,000USD
    Net Working Capital—3,375,000,000USD4,557,000,000USD4,917,000,000USD4,599,000,000USD5,162,000,000USD5,893,000,000USD7,465,000,000USD
    Unclassified Non Current Assets—244,000,000USD81,000,000USD181,000,000USD81,000,000USD81,000,000USD81,000,000USD81,000,000USD
    Unclassified Non Current Liabilities—1,065,000,000USD1,075,000,000USD1,082,000,000USD1,000,000,000USD994,000,000USD999,000,000USD1,640,000,000USD
    Unclassified Equity—1,503,000,000USD1,382,000,000USD1,254,000,000USD1,127,000,000USD982,000,000USD866,000,000USD751,000,000USD
    SourceDisclosureDeterministicFinalLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Balance sheet Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20252025-12-31 · USDFY 20242024-12-31 · USDFY 20232023-12-31 · USDFY 20222022-12-31 · USDFY 20212021-12-31 · USDFY 20202020-12-31 · USDFY 20192019-12-31 · USDFY 20182018-12-31 · USD
    Total Assets12,338,000,000USD14,142,000,000USD18,426,000,000USD25,858,000,000USD24,669,000,000USD7,337,000,000USD1,589,422,000USD1,962,149,000USD
    Intangible Assets45,000,000USD40,000,000USD44,000,000USD—————
    Other Current Assets308,000,000USD365,000,000USD438,000,000USD895,000,000USD580,000,000USD235,000,000USD9,507,000USD10,996,000USD
    Total Liab3,688,000,000USD3,241,000,000USD4,572,000,000USD6,735,000,000USD10,524,000,000USD4,776,000,000USD414,612,000USD431,908,000USD
    Total Stockholder Equity8,650,000,000USD10,901,000,000USD13,854,000,000USD19,123,000,000USD14,145,000,000USD2,561,000,000USD1,174,810,000USD1,530,241,000USD
    Other Current Liab1,571,000,000USD1,608,000,000USD1,839,000,000USD2,154,000,000USD1,486,000,000USD474,000,000USD72,715,000USD3,464,000USD
    Capital Stock0USD0USD0USD0USD0USD40,000USD34,000USD33,000USD
    Retained Earnings7,223,000,000USD10,045,000,000USD13,606,000,000USD18,320,000,000USD9,958,000,000USD-2,244,000,000USD-1,496,454,000USD-1,006,627,000USD
    Good Will52,000,000USD52,000,000USD52,000,000USD0USD————
    Cash2,595,000,000USD1,927,000,000USD2,907,000,000USD3,205,000,000USD6,848,000,000USD2,624,000,000USD235,876,000USD658,364,000USD
    Cash And Short Term Investments5,799,000,000USD7,025,000,000USD8,604,000,000USD9,902,000,000USD10,727,000,000USD4,608,000,000USD1,103,000,000USD1,694,417,000USD
    Total Current Assets6,544,000,000USD8,099,000,000USD10,325,000,000USD13,431,000,000USD16,071,000,000USD6,298,000,000USD1,128,804,000USD1,563,006,000USD
    Total Current Liabilities1,987,000,000USD2,206,000,000USD3,015,000,000USD4,923,000,000USD9,128,000,000USD4,389,000,000USD143,115,000USD222,803,000USD
    Current Deferred Revenue99,000,000USD153,000,000USD568,000,000USD2,038,000,000USD6,253,000,000USD3,867,000,000USD63,310,000USD109,056,000USD
    Net Debt-679,000,000USD-1,180,000,000USD-1,664,000,000USD-2,005,000,000USD-5,932,000,000USD-2,387,000,000USD-103,512,000USD-624,875,000USD
    Short Long Term Debt Total1,916,000,000USD747,000,000USD1,243,000,000USD1,200,000,000USD916,000,000USD237,000,000USD132,364,000USD112,562,000USD
    Long Term Debt590,000,000USD———————
    Long Term Investments2,342,000,000USD2,508,000,000USD4,743,000,000USD8,318,000,000USD6,843,000,000USD638,848,000USD159,987,000USD172,990,000USD
    Short Term Investments3,204,000,000USD5,098,000,000USD5,697,000,000USD6,697,000,000USD3,879,000,000USD1,984,000,000USD867,124,000USD863,063,000USD
    Net Receivables284,000,000USD592,000,000USD1,081,000,000USD1,685,000,000USD3,323,000,000USD1,408,000,000USD16,297,000USD30,583,000USD
    Inventory153,000,000USD117,000,000USD202,000,000USD949,000,000USD1,441,000,000USD47,000,000USD-904,193,000USD-172,990,000USD
    Accounts Payable317,000,000USD405,000,000USD520,000,000USD487,000,000USD302,000,000USD18,000,000USD7,090,000USD31,210,000USD
    Property Plant Equipment Net2,853,000,000USD2,955,000,000USD2,658,000,000USD2,139,000,000USD1,383,000,000USD387,000,000USD287,909,000USD211,977,000USD
    Property Plant Equipment Gross3,590,000,000USD3,482,000,000USD3,091,000,000USD2,139,000,000USD1,735,000,000USD387,090,000USD287,909,000USD211,977,000USD
    Accumulated Other Comprehensive Income45,000,000USD-10,000,000USD-123,000,000USD-370,000,000USD-24,000,000USD3,000,000USD1,804,000USD-1,320,000USD
    Common Stock Shares Outstanding389,000,000shares384,000,000shares382,000,000shares416,000,000shares431,000,000shares381,333,059shares330,802,136shares81,114,183shares
    Non Current Assets Total5,794,000,000USD6,043,000,000USD8,101,000,000USD12,427,000,000USD8,598,000,000USD1,039,000,000USD460,618,000USD399,143,000USD
    Non Current Liabilities Total1,701,000,000USD1,035,000,000USD1,557,000,000USD1,812,000,000USD1,396,000,000USD387,000,000USD271,497,000USD209,105,000USD
    Non Current Liabilities Other36,000,000USD36,000,000USD256,000,000USD135,000,000USD1,396,000,000USD386,567,000USD138,000USD258,000USD
    Non Currrent Assets Other421,000,000USD407,000,000USD523,000,000USD946,000,000USD46,000,000USD13,000,000USD12,722,000USD14,176,000USD
    Net Working Capital4,557,000,000USD5,893,000,000USD7,310,000,000USD8,508,000,000USD6,943,000,000USD1,909,071,000USD985,689,000USD1,340,203,000USD
    Unclassified Non Current Assets81,000,000USD81,000,000USD—-904,000,000USD-7,057,000,000USD-741,830,000USD-12,722,000USD-14,176,000USD
    Unclassified Non Current Liabilities1,075,000,000USD999,000,000USD1,301,000,000USD869,000,000USD-691,000,000USD-178,839,000USD132,226,000USD33,231,000USD
    Unclassified Equity1,382,000,000USD866,000,000USD371,000,000USD1,173,000,000USD5,068,000,000USD4,801,920,000USD2,669,392,000USD2,538,122,000USD
    Short Term Debt—37,000,000USD25,000,000USD196,000,000USD211,000,000USD30,000,000USD67,652,000USD79,073,000USD
    Unclassified Current Liabilities——63,000,000USD—876,000,000USD—-67,652,000USD—
    Other Liab———808,000,000USD691,000,000USD179,272,000USD139,133,000USD175,616,000USD
    Other Assets———1,928,000,000USD7,383,000,000USD741,982,000USD12,722,000USD14,176,000USD
    Net Tangible Assets———19,123,000,000USD14,145,000,000USD2,561,375,000USD1,174,810,000USD1,530,241,000USD
    Common Stock————-857,000,000USD40,000USD34,000USD33,000USD
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Cash flow YTD

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ2 20262026-06-30 · USD
    Depreciation112,000,000USD
    Stock Based Compensation224,000,000USD
    Other Non Cash Items-10,000,000USD
    Change To Account Receivables167,000,000USD
    Change To Inventory-126,000,000USD
    Change To Liabilities320,000,000USD
    Change In Working Capital-44,000,000USD
    Operating Cash Flow-1,156,000,000USD
    Capital Expenditures-99,000,000USD
    Net Investments352,000,000USD
    Investing Cash Flow253,000,000USD
    Common Stock Issuance42,000,000USD
    Net Common Stock Issuance-4,000,000USD
    Unclassified Financing Cash Flow-7,000,000USD
    Financing Cash Flow31,000,000USD
    Effect Of Forex Changes On Cash-1,000,000USD
    Change In Cash-873,000,000USD
    End Cash Flow1,724,000,000USD
    SourceDisclosureDeterministicFinal

    Cash flow Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ1 20262026-03-31 · USDQ4 20252025-12-31 · USDQ3 20252025-09-30 · USDQ2 20252025-06-30 · USDQ1 20252025-03-31 · USDQ4 20242024-12-31 · USDQ3 20242024-09-30 · USDQ2 20242024-06-30 · USD
    Net Income-1,343,000,000USD-826,000,000USD-200,000,000USD-825,000,000USD-971,000,000USD-1,120,000,000USD13,000,000USD-1,279,000,000USD
    Depreciation59,000,000USD67,000,000USD52,000,000USD57,000,000USD39,000,000USD60,000,000USD52,000,000USD41,000,000USD
    Stock Based Compensation104,000,000USD113,000,000USD125,000,000USD130,000,000USD115,000,000USD104,000,000USD112,000,000USD112,000,000USD
    Other Non Cash Items-3,000,000USD197,000,000USD-6,000,000USD16,000,000USD-9,000,000USD44,000,000USD-1,829,000,000USD-2,000,000USD
    Change To Account Receivables114,000,000USD859,000,000USD-1,013,000,000USD30,000,000USD280,000,000USD1,206,000,000USD-1,401,000,000USD-26,000,000USD
    Change To Inventory6,000,000USD179,000,000USD-91,000,000USD-114,000,000USD-8,000,000USD291,000,000USD-11,000,000USD-104,000,000USD
    Change In Working Capital553,000,000USD1,580,000,000USD-818,000,000USD-297,000,000USD-211,000,000USD1,737,000,000USD86,000,000USD-146,000,000USD
    Total Cash From Operating Activities-630,000,000USD951,000,000USD-847,000,000USD-919,000,000USD-1,037,000,000USD825,000,000USD-1,566,000,000USD-1,274,000,000USD
    Capital Expenditures-62,000,000USD-39,000,000USD-33,000,000USD-3,000,000USD-127,000,000USD-522,000,000USD-151,000,000USD-182,000,000USD
    Free Cash Flow-692,000,000USD912,000,000USD-880,000,000USD-922,000,000USD-1,164,000,000USD303,000,000USD-1,717,000,000USD-1,456,000,000USD
    Investments-14,000,000USD-9,000,000USD700,000,000USD564,000,000USD730,000,000USD-539,000,000USD721,000,000USD1,649,000,000USD
    Total Cashflows From Investing Activities-76,000,000USD-48,000,000USD700,000,000USD564,000,000USD730,000,000USD-539,000,000USD721,000,000USD1,649,000,000USD
    Net Borrowings0USD566,000,000USD-3,000,000USD-5,000,000USD2,000,000USD-14,000,000USD3,000,000USD—
    Total Cash From Financing Activities17,000,000USD560,000,000USD-1,000,000USD9,000,000USD4,000,000USD-3,000,000USD11,000,000USD34,000,000USD
    Issuance Of Capital Stock19,000,000USD16,000,000USD2,000,000USD14,000,000USD3,000,000USD11,000,000USD8,000,000USD32,000,000USD
    Change In Cash-688,000,000USD1,462,000,000USD-147,000,000USD-345,000,000USD-303,000,000USD282,000,000USD-833,000,000USD409,000,000USD
    Begin Period Cash Flow2,597,000,000USD1,133,000,000USD1,280,000,000USD1,626,000,000USD1,929,000,000USD1,647,000,000USD2,480,000,000USD2,071,000,000USD
    End Period Cash Flow1,909,000,000USD2,595,000,000USD1,132,000,000USD1,281,000,000USD1,626,000,000USD1,929,000,000USD1,647,000,000USD2,480,000,000USD
    Other Cashflows From Financing Activities-2,000,000USD-1,000,000USD-1,000,000USD-5,000,000USD-1,000,000USD—721,000,000USD1,649,000,000USD
    Unclassified Operating Cash Flow—-180,000,000USD——————
    Unclassified Financing Cash Flow—-21,000,000USD—5,000,000USD—11,000,000USD-713,000,000USD-1,615,000,000USD
    Unclassified Investing Cash Flow——33,000,000USD—137,000,000USD522,000,000USD151,000,000USD182,000,000USD
    Other Cashflows From Investing Activities————-10,000,000USD———
    Sale Purchase Of Stock—————0USD0USD0USD
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Cash flow Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20252025-12-31 · USDFY 20242024-12-31 · USDFY 20232023-12-31 · USDFY 20222022-12-31 · USDFY 20212021-12-31 · USDFY 20202020-12-31 · USDFY 20192019-12-31 · USDFY 20182018-12-31 · USD
    Net Income-2,822,000,000USD-3,561,000,000USD-4,714,000,000USD8,362,000,000USD12,202,000,000USD-747,064,000USD-514,021,000USD-384,734,000USD
    Depreciation215,000,000USD189,000,000USD621,000,000USD348,000,000USD232,000,000USD31,251,000USD31,021,000USD24,862,000USD
    Stock Based Compensation483,000,000USD429,000,000USD305,000,000USD226,000,000USD142,000,000USD93,021,000USD81,122,000USD72,565,000USD
    Other Non Cash Items-3,000,000USD17,000,000USD-19,000,000USD59,000,000USD372,000,000USD62,286,000USD-3,426,000USD-975,000USD
    Change To Account Receivables156,000,000USD534,000,000USD493,000,000USD1,790,000,000USD-1,784,000,000USD-1,385,191,000USD7,216,000USD832,000USD
    Change To Inventory-34,000,000USD83,000,000USD747,000,000USD492,000,000USD-1,394,000,000USD-46,527,000USD7,203,000USD4,408,000USD
    Change In Working Capital254,000,000USD-78,000,000USD-139,000,000USD-3,455,000,000USD990,000,000USD2,577,054,000USD-53,664,000USD-42,583,000USD
    Total Cash From Operating Activities-1,873,000,000USD-3,004,000,000USD-3,118,000,000USD4,981,000,000USD13,620,000,000USD2,026,971,000USD-458,968,000USD-330,865,000USD
    Capital Expenditures-192,000,000USD-1,051,000,000USD-707,000,000USD-400,000,000USD-284,000,000USD-67,448,000USD-31,554,000USD-105,766,000USD
    Free Cash Flow-2,065,000,000USD-4,055,000,000USD-3,825,000,000USD4,581,000,000USD13,336,000,000USD1,959,523,000USD-490,522,000USD-436,631,000USD
    Investments2,148,000,000USD1,949,000,000USD3,696,000,000USD-5,176,000,000USD-8,239,000,000USD-1,604,480,000USD16,609,000USD-267,328,000USD
    Total Cashflows From Investing Activities1,946,000,000USD1,949,000,000USD4,206,000,000USD-5,176,000,000USD-8,523,000,000USD-1,671,928,000USD-14,945,000USD-372,472,000USD
    Net Borrowings560,000,000USD-10,000,000USD-270,000,000USD-184,000,000USD-140,000,000USD-6,215,000USD971,000USD9,460,000USD
    Total Cash From Financing Activities593,000,000USD56,000,000USD-1,377,000,000USD-3,448,000,000USD-873,000,000USD2,033,193,000USD51,121,000USD1,226,842,000USD
    Issuance Of Capital Stock35,000,000USD66,000,000USD46,000,000USD65,000,000USD-275,000USD1,852,725,000USD549,455,000USD1,224,137,000USD
    Change In Cash668,000,000USD-999,000,000USD-289,000,000USD-3,643,000,000USD4,224,000,000USD2,388,236,000USD-422,792,000USD523,505,000USD
    Begin Period Cash Flow1,929,000,000USD2,928,000,000USD3,217,000,000USD6,860,000,000USD2,636,000,000USD247,699,000USD670,491,000USD134,859,000USD
    End Period Cash Flow2,597,000,000USD1,929,000,000USD2,928,000,000USD3,217,000,000USD6,860,000,000USD2,635,935,000USD247,699,000USD658,364,000USD
    Other Cashflows From Investing Activities-10,000,000USD—-23,000,000USD-40,000,000USD-30,000,000USD-30,000,000USD-55,000USD622,000USD
    Other Cashflows From Financing Activities19,000,000USD56,000,000USD4,206,000,000USD-5,176,000,000USD124,000,000USD186,683,000USD-29,000USD652,929,000USD
    Unclassified Financing Cash Flow-21,000,000USD10,000,000USD-3,890,000,000USD5,425,000,000USD124,000,000USD1,852,725,000USD47,288,000USD572,635,000USD
    Sale Purchase Of Stock—0USD-1,153,000,000USD-3,329,000,000USD-857,000,000USD7,040,000USD2,891,000USD-8,182,000USD
    Unclassified Investing Cash Flow—1,051,000,000USD1,240,000,000USD440,000,000USD—30,000,000USD——
    Dividends Paid——-270,000,000USD-184,000,000USD-124,000,000USD-7,040,000USD——
    Unclassified Operating Cash Flow——828,000,000USD-559,000,000USD-318,000,000USD———
    Change To Liabilities———112,000,000USD2,192,000,000USD406,256,000USD-77,614,000USD-40,546,000USD
    Cash And Cash Equivalents Changes———-3,643,000,000USD4,224,000,000USD2,388,236,000USD-422,792,000USD523,505,000USD
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Operating metrics

    No operating metrics are currently published for this company.

    Revenue breakdown

    PeriodDimensionBusiness / regionRevenueCurrencySource
    Q2 2026Quarterly · 2026-06-30ProductCollaboration Arrangement Including Arrangements With Affiliate15,000,000USDDisclosure
    Q2 2026Quarterly · 2026-06-30ProductGrant2,000,000USDDisclosure
    Q2 2026Quarterly · 2026-06-30ProductLicense And Royalty3,000,000USDDisclosure
    Q2 2026Quarterly · 2026-06-30ProductProduct Sales — COVID1991,000,000USDDisclosure
    Q2 2026Quarterly · 2026-06-30ProductProduct Sales — RSV3,000,000USDDisclosure
    Q2 2026Quarterly · 2026-06-30ProductStand Ready Manufacturing31,000,000USDDisclosure
    Q1 2026Quarterly · 2026-03-31ProductCollaboration Arrangement Including Arrangements With Affiliate5,000,000USD0001682852-26-000060
    Q1 2026Quarterly · 2026-03-31ProductGrant0USD0001682852-26-000060
    Q1 2026Quarterly · 2026-03-31ProductLicense And Royalty0USD0001682852-26-000060
    Q1 2026Quarterly · 2026-03-31ProductProduct Sales — COVID19345,000,000USD0001682852-26-000060
    Q1 2026Quarterly · 2026-03-31ProductProduct Sales — RSV7,000,000USD0001682852-26-000060
    Q1 2026Quarterly · 2026-03-31ProductStand Ready Manufacturing32,000,000USD0001682852-26-000060
    FY 2025Yearly · 2025-12-31GeographyEurope53,000,000USD0001682852-26-000033
    FY 2025Yearly · 2025-12-31GeographyRest of World692,000,000USD0001682852-26-000033
    FY 2025Yearly · 2025-12-31GeographyUnited States1,199,000,000USD0001682852-26-000033
    FY 2025Yearly · 2025-12-31ProductCollaboration Arrangement Including Arrangements With Affiliate13,000,000USD0001682852-26-000033
    FY 2025Yearly · 2025-12-31ProductGrant22,000,000USD0001682852-26-000033
    FY 2025Yearly · 2025-12-31ProductLicense And Royalty11,000,000USD0001682852-26-000033
    FY 2025Yearly · 2025-12-31ProductProduct Sales — COVID191,810,000,000USD0001682852-26-000033
    FY 2025Yearly · 2025-12-31ProductProduct Sales — RSV8,000,000USD0001682852-26-000033
    FY 2025Yearly · 2025-12-31ProductStand Ready Manufacturing Revenue80,000,000USD0001682852-26-000033
    Q3 2025Quarterly · 2025-09-30ProductCollaboration Arrangement Including Arrangements With Affiliate7,000,000USD0001682852-25-000075
    Q3 2025Quarterly · 2025-09-30ProductGrant14,000,000USD0001682852-25-000075
    Q3 2025Quarterly · 2025-09-30ProductLicense And Royalty2,000,000USD0001682852-25-000075
    Q3 2025Quarterly · 2025-09-30ProductOther Revenue20,000,000USD0001682852-25-000075
    Q3 2025Quarterly · 2025-09-30ProductProduct Sales — COVID19971,000,000USD0001682852-25-000075
    Q3 2025Quarterly · 2025-09-30ProductProduct Sales — RSV2,000,000USD0001682852-25-000075
    Q1 2025Quarterly · 2025-03-31ProductCOVID1984,000,000USD0001682852-26-000060
    Q1 2025Quarterly · 2025-03-31ProductLicense And Royalty8,000,000USD0001682852-26-000060
    Q1 2025Quarterly · 2025-03-31ProductOther14,000,000USD0001682852-26-000060
    Q1 2025Quarterly · 2025-03-31ProductRSV — Collaboration Arrangement Including Arrangements With Affiliate1,000,000USD0001682852-26-000060
    Q1 2025Quarterly · 2025-03-31ProductRSV — Grant1,000,000USD0001682852-26-000060
    FY 2024Yearly · 2024-12-31GeographyEurope598,000,000USD0001682852-26-000033
    FY 2024Yearly · 2024-12-31GeographyRest of World853,000,000USD0001682852-26-000033
    FY 2024Yearly · 2024-12-31GeographyUnited States1,785,000,000USD0001682852-26-000033
    FY 2024Yearly · 2024-12-31ProductCollaboration Arrangement Including Arrangements With Affiliate48,000,000USD0001682852-26-000033
    FY 2024Yearly · 2024-12-31ProductGrant37,000,000USD0001682852-26-000033
    FY 2024Yearly · 2024-12-31ProductLicense And Royalty42,000,000USD0001682852-26-000033
    FY 2024Yearly · 2024-12-31ProductProduct Sales — COVID193,084,000,000USD0001682852-26-000033
    FY 2024Yearly · 2024-12-31ProductProduct Sales — RSV25,000,000USD0001682852-26-000033
    FY 2024Yearly · 2024-12-31ProductStand Ready Manufacturing Revenue0USD0001682852-26-000033
    Q3 2024Quarterly · 2024-09-30ProductCollaboration Arrangement Including Arrangements With Affiliate28,000,000USD0001682852-24-000060
    Q3 2024Quarterly · 2024-09-30ProductGrant7,000,000USD0001682852-24-000060
    Q3 2024Quarterly · 2024-09-30ProductLicense And Royalty7,000,000USD0001682852-24-000060
    Q3 2024Quarterly · 2024-09-30ProductProduct Sales — COVID191,810,000,000USD0001682852-24-000060
    Q3 2024Quarterly · 2024-09-30ProductProduct Sales — RSV10,000,000USD0001682852-24-000060
    Q2 2024Quarterly · 2024-06-30ProductCollaboration Arrangement Including Arrangements With Affiliate7,000,000USD0001682852-24-000046
    Q2 2024Quarterly · 2024-06-30ProductGrant20,000,000USD0001682852-24-000046
    Q2 2024Quarterly · 2024-06-30ProductLicense And Royalty30,000,000USD0001682852-24-000046
    Q2 2024Quarterly · 2024-06-30ProductProduct Sales184,000,000USD0001682852-24-000046
    Q1 2024Quarterly · 2024-03-31ProductCollaboration Arrangement Including Arrangements With Affiliate0USD0001682852-24-000027
    Q1 2024Quarterly · 2024-03-31ProductGrant0USD0001682852-24-000027
    Q1 2024Quarterly · 2024-03-31ProductProduct And Service Other0USD0001682852-24-000027
    Q1 2024Quarterly · 2024-03-31ProductProduct Sales167,000,000USD0001682852-24-000027
    Q4 2023Quarterly · 2023-12-31ProductCollaboration Arrangement Including Arrangements With Affiliate20,000,000USDLegacy provider
    Q4 2023Quarterly · 2023-12-31ProductGrant0USDLegacy provider
    Q4 2023Quarterly · 2023-12-31ProductProduct Sales2,793,000,000USDLegacy provider
    FY 2023Yearly · 2023-12-31GeographyEurope1,355,000,000USD0001682852-26-000033
    FY 2023Yearly · 2023-12-31GeographyRest of World3,598,000,000USD0001682852-26-000033
    FY 2023Yearly · 2023-12-31GeographyUnited States1,895,000,000USD0001682852-26-000033
    FY 2023Yearly · 2023-12-31ProductCollaboration Arrangement Including Arrangements With Affiliate83,000,000USD0001682852-24-000015
    FY 2023Yearly · 2023-12-31ProductGrant94,000,000USD0001682852-24-000015
    FY 2023Yearly · 2023-12-31ProductProduct Sales6,671,000,000USD0001682852-24-000015
    FY 2022Yearly · 2022-12-31GeographyEurope6,815,000,000USD0001682852-25-000022
    FY 2022Yearly · 2022-12-31GeographyRest of World7,298,000,000USD0001682852-25-000022
    FY 2022Yearly · 2022-12-31GeographyUnited States5,150,000,000USD0001682852-25-000022
    FY 2022Yearly · 2022-12-31ProductCollaboration Arrangement Including Arrangements With Affiliate440,000,000USD0001682852-24-000015
    FY 2022Yearly · 2022-12-31ProductGrant388,000,000USD0001682852-24-000015
    FY 2022Yearly · 2022-12-31ProductProduct Sales18,435,000,000USD0001682852-24-000015
    FY 2021Yearly · 2021-12-31GeographyEurope6,846,000,000USD0001682852-24-000015
    FY 2021Yearly · 2021-12-31GeographyRest of World5,448,000,000USD0001682852-24-000015
    FY 2021Yearly · 2021-12-31GeographyUnited States6,177,000,000USD0001682852-24-000015
    FY 2021Yearly · 2021-12-31ProductCollaboration Arrangement Including Arrangements With Affiliate61,000,000USD0001682852-24-000015
    FY 2021Yearly · 2021-12-31ProductGrant735,000,000USD0001682852-24-000015
    FY 2021Yearly · 2021-12-31ProductProduct Sales17,675,000,000USD0001682852-24-000015
    FY 2020Yearly · 2020-12-31GeographyEurope33,000,000USD0001682852-23-000011
    FY 2020Yearly · 2020-12-31GeographyRest of World6,000,000USD0001682852-23-000011
    FY 2020Yearly · 2020-12-31GeographyUnited States764,000,000USD0001682852-23-000011
    FY 2020Yearly · 2020-12-31ProductCollaboration Arrangement74,000,000USD0001682852-23-000011
    FY 2020Yearly · 2020-12-31ProductGrant529,000,000USD0001682852-23-000011
    FY 2020Yearly · 2020-12-31ProductProduct Sales200,000,000USD0001682852-23-000011
    FY 2019Yearly · 2019-12-31GeographyEurope5,000,000USD0001682852-22-000012
    FY 2019Yearly · 2019-12-31GeographyRest of World0USD0001682852-22-000012
    FY 2019Yearly · 2019-12-31GeographyUnited States55,000,000USD0001682852-22-000012
    FY 2019Yearly · 2019-12-31ProductCollaboration Arrangement48,000,000USD0001682852-22-000012
    FY 2019Yearly · 2019-12-31ProductGrant12,000,000USD0001682852-22-000012
    FY 2019Yearly · 2019-12-31ProductProduct Sales0USD0001682852-22-000012
    FY 2018Yearly · 2018-12-31GeographyInternational45,993,000USD0001682852-21-000006
    FY 2018Yearly · 2018-12-31GeographyUnited States89,075,000USD0001682852-21-000006
    FY 2018Yearly · 2018-12-31ProductCollaboration Arrangement122,512,000USD0001682852-21-000006
    FY 2018Yearly · 2018-12-31ProductGrant12,556,000USD0001682852-21-000006
    FY 2018Yearly · 2018-12-31ProductProduct Sales0USD0001682852-21-000006

    Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.